$CVRX News

CVRx to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call on August 6, 2026

CVRx, Inc. (CVRX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

CVRx Announces Chief Financial Officer Transition

CVRx CFO Jared Oasheim Stepping Down

CVRx, Inc. (CVRX) Presents at 46th Annual William Blair Growth Stock Conference - Slideshow

CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

CVRx to Present at the William Blair 46th Annual Growth Stock Conference

Analysts Have Made A Financial Statement On CVRx, Inc.'s (NASDAQ:CVRX) First-Quarter Report

CVRx Announces Humana Medicare Advantage Coverage Policy For The Company's Barostim Therapy, Effective May 1

Down 31.7% in 4 Weeks, Here's Why You Should You Buy the Dip in CVRx (CVRX)

CVRx Inc (CVRX) Q1 2026 Earnings Call Highlights: Strong U.S. Growth and Market Expansion Potential

CVRx Q1 Earnings Call Highlights

CVRX Inc (NASDAQ:CVRX) Q1 2026 Earnings Meet Revenue Estimates, Loss Slightly Narrower Than Expected

CVRx Reports First Quarter 2026 Financial and Operating Results

CVRx, Inc. (CVRX) Q1 2026 Earnings Call Transcript

CVRx Affirms FY2026 Sales Guidance of $63.000M-$67.000M vs $65.119M Est.

CVRx Sees Q2 Sales $15.100M-$16.100M vs $15.661M Est.

CVRx Q1 EPS $(0.50) Beats $(0.52) Estimate, Sales $14.769M Beat $14.481M Estimate.

CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population

CVRx Enrolls First Participant In BENEFIT-HF Study To Evaluate Barostim